Anatomolecular imaging with 2-deoxy-2-[ 18 F] fluoro-D-glucose: Bench to outpatient center

Molecular Imaging and Biology

Volumn 5, Issue 2, 2003, Pages 49-56

  Wahl, Richard L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AMI; Cancer; CT; FDG; Glucose transporter; Hexokinase; Image fusion; Imaging; Metabolism; Molecular imaging; MRI; Nuclear; PET; PET CT; Photon; Radiotracer; X ray

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RECEPTOR BLOCKING AGENT; TRACER;

CANCER DIAGNOSIS; CANCER SIZE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG UPTAKE; GENOTYPE; GLUCOSE METABOLISM; HUMAN; IMAGING SYSTEM; MOLECULAR GENETICS; NONHUMAN; OUTPATIENT DEPARTMENT; PATHOLOGICAL ANATOMY; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RAT; RELIABILITY; REVIEW; X RAY;

EID: 0037942736     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1536-1632(03)00045-3     Document Type: Article

References (50)

1. Wahl R.L. Quint L.E. Cieslak R.D. et al. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity J. Nucl. Med. 34 1993 1190-1197
2. Anzai Y. Carroll W.R. Quint D.J. et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology 200 1996 135-141
3. Sugawara Y. Zasadny K.R. Grossman H.B. et al. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling Radiology 211 1999 249-256
4. Zhang W. Laborde P.M. Coombes K.R. et al. Cancer genomics: promises and complexities Clin. Cancer Res. 7 2001 2159-2167
5. Warburg O. The metabolism of tumors 1931 Richard, R., Smith, Inc New York
6. Phelps M.E. Huang S.C. Hoffman E.J. et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (18F)2-fluoro-2-deoxy-D-glucose: validation of method Ann. Neurol. 6 1979 371-388
7. Som P. Atkins H.L. Bandoypadhyay D. et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (18F): nontoxic tracer for rapid tumor detection J. Nuc. Med. 21 1980 670-675
8. Larson S.M. Weiden P.L. Grunbaum Z. et al. Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication J. Nucl. Med. 22 1981 875-879
9. Patronas N.J. DiChiro G. Brooks R.A. et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain Radiology 144 1982 885-889
10. Yonekura Y. Benua R.S. Brill A.B. et al. Increased accumulation of 2-deoxy-2-18F]Fluoro-D-glucose in liver metastases from colon carcinoma J. Nucl. Med. 23 1982 1133-1137
11. Kern K.A. Brunetti A. Norton J.A. et al. Metabolic imaging of human extremity musculoskeletal tumors by PET J. Nucl. Med. 29 1988 181-186
12. Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging or detection of lymphoma J. Nucl. Med. 28 1987 288-292
13. Strauss L.G. Clorius J.H. Schlag P. et al. Recurrence of colorectal tumors: PET evaluation Radiology 170 1989 329-332
14. Fujiwara T. Matsuzawa T. Kubota K. et al. Relationship between histologic type of primary lung cancer and Carbon 11 L methionine uptake with positron emission tomography J. Nuc. Med. 30 1989 33-37
15. Wahl R.L. Kaminski M.S. Ethier S.P. et al. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes J. Nucl. Med. 31 1990 1831-1835
16. Wahl R.L. Hutchins G.D. Buchsbaum D.J. et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography Cancer 67 1991 1544-1550
17. Wahl R.L. Cody R.L. Hutchins G.D. et al. PET imaging of breast cancer with 18F-FDG Radiology 173 1989 419 [abstract]
18. Wahl R.L. Cody R. Hutchins G.D. et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analog 2-[18F]-fluoro-deoxy-2-D-glucose (FDG) Radiology 79 1991 765-770
19. Wahl R.L. Harney J. Hutchins G. et al. Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies J. Urol. 146 1991 1470-1474
20. Harney J.V. Wahl R.L. Liebert M. et al. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography J. Urol. 145 1991 279-283
21. Wahl R.L. Hutchins G.D. Roberts J. FDG PET imaging of ovarian cancer: initial evaluation in patients J. Nucl. Med. 32 1991 982 [abstract]
22. Gritters L.S. Francis I.R. Zasadny K.R.et al. Initial assessment of positron emission tomography using 2-fluorine-18Fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma J. Nucl. Med. 34 1993 1420-1427
23. Kubota K. Matsuzawa T. Amemiya A. et al. Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography J. Comput. Assist. Tomogr. 13 1989 1097-1098
24. Dahlbom M. Hoffman E.J. Hoh C.K. et al. Whole-body positron emission tomography: Part I. Methods and performance characteristics J. Nucl. Med. 33 1982 1191-1199
25. Rosenfeld S.S. Hoffman J.M. Coleman R.E. et al. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography J. Nucl. Med. 33 1982 532-536
26. Hoh C.K. Hawkins R.A. Glaspy J.A. et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose J. Comput. Assist. Tomogr. 17 1993 582-589
27. Brown R.S. Wahl R.L. Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study Cancer 72 1993 2979-2985
28. Brown R.S. Fisher S.J. Wahl R.L. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma J. Nucl. Med. 34 1993 75-82
29. Higashi K. Clavo A.C. Wahl R.L. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake J. Nucl. Med. 34 1993 414-419
30. Brown R.S. Leung J.Y. Fisher S.J. et al. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake J. Nucl. Med. 37 1996 1042-1047
31. Brown R.S. Leung J.Y. Kison P.V. et al. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer J. Nucl. Med. 40 1999 556-565
32. Wahl R.L. Henry C.A. Ethier S.P. Serum glucose: effects on tumor and normal tissue accumulation of 2-[18F]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma Radiology 183 1992 643-647
33. Torizuka T. Fisher S.J. Brown R.S. Wahl R.L. Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats Radiology 208 1998 499-504
34. Torizuka T. Fisher S.J. Wahl R.L. Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma Radiology 203 1997 169-172
35. Clavo A.C. Brown R.S. Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia J. Nucl. Med. 36 1995 1625-1632
36. Clavo A.C. Wahl R.L. Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells J. Nucl. Med. 37 1996 502-506
37. Kubota R. Yamada S. Kubota K. et al. Intratumoral distribution of fluorine-18Fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J. Nucl. Med. 33 1992 1972-1980
38. Brown R.S. Leung J.Y. Fisher S.J. et al. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J. Nucl. Med. 36 1995 1854-1861
39. Sugawara Y. Braun D.K. Kison P.V. et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results Eur. J. Nucl. Med. 25 1998 1238-1243
40. Higashi K. Clavo A.C. Wahl R.L. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy J. Nucl. Med. 34 1993 773-779
41. Wahl R.L. Zasadny K.R. Hutchins G.D. et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography (PET): Initial evaluation J. Clin. Oncol. 11 1993 2101-2111
42. Higashi K. Ueda Y. Seki H. et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma J. Nucl. Med. 39 1998 1016-1020
43. Aloj L. Caraco C. Joagoda E. et al. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture Cancer Res 59 1999 4709-4714
44. Brown R.S. Goodman T.M. Zasadny K.R. et al. Expression of hexokinase II and Glut-1 in untreated human breast cancer Nucl Med Biol 29 2002 443-453
45. Zasadny K.R. Tatsumi M. Wahl R.L. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers Eur J Nucl Med Mol Imaging 30 2003 274-280
46. 18 F]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system J. Biol. Chem. 275 2000 18489-18494
47. Skalski J. Wahl R.L. Meyer C.R. Comparison of mutual information-based warping accuracy for fusing body CT and PET by 2 methods: CT mapped onto PET emission scan versus CT mapped onto PET transmission scan J. Nucl. Med. 43 2002 1184-1187
48. Beyer T. Townsend D.W. Brun T. et al. A combined PET/CT scanner for clinical oncology J. Nucl. Med. 41 2000 1369-1379
49. Hany T.F. Steinert H.C. Goerres G.W. et al PET diagnostic accuracy: improvement with in-line PET-CT system: initial results Radiology 225 2002 575-581
50. Nakamoto Y. Osman M. Cohade C. et al PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images J. Nucl. Med. 43 2002 1137-1143